Medical Condition News

RSS

Study explains long-term ocular symptoms following mild COVID-19

Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden.

8 Jul 2026

Sleep apnea and erectile dysfunction share a stronger link than expected

A systematic review and meta-analysis of 8 observational studies found that greater obstructive sleep apnea severity was associated with poorer erectile function, with higher AHI linked to lower IIEF scores and higher minimum oxygen saturation linked to higher IIEF scores. The authors caution that the evidence remains observational, heterogeneous, and low certainty, so the findings support targeted screening rather than proving causality.

8 Jul 2026

Yogurt, prebiotics, and probiotics link to lower colorectal cancer odds in U.S. adults

A national NHANES analysis of 9,405 U.S. adults aged 50 and older found that any yogurt, prebiotic, or probiotic consumption was associated with about 50% lower odds of self-reported colorectal cancer. Because the study was cross-sectional, it cannot prove causation but supports further research into microbiota-targeted dietary strategies.

8 Jul 2026

Persistent high cortisol levels increase hypertension risk in patients with adrenal tumors

A major new study, published today in The Lancet Diabetes & Endocrinology has shown that cortisol levels in patients with adrenal tumours are far less stable than previously assumed.

7 Jul 2026

Study uncovers genetic clues behind sex differences in Parkinson's disease

New research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2026 has discovered some of the genetic changes in brain cells that may help to explain why more men than women develop Parkinson's disease.

7 Jul 2026

Using manganese ferrite nanoparticles to better harness heat against cancer

Scientists have long known that heat can be used to help fight cancer. But heating up tumors and cancer cells is trickier than it sounds.

7 Jul 2026

Injectable opioid treatment sees rapid growth across the United States

There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, according to a Rutgers Health study.

7 Jul 2026

Infrared imaging improves at-home eczema hydration monitoring

Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear responses to at-home moisturizers, and measurement systems that don't penetrate into the deep layers of skin affected by disease.

7 Jul 2026

Updated ABCs framework gives clinicians a clearer path to prevent heart disease

A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in routine care. The framework emphasizes PREVENT™ risk equations, Life’s Essential 8, CKM syndrome, obesity care, lipid lowering, blood pressure control, healthy aging, heart failure prevention, and atrial fibrillation management.

7 Jul 2026

Study reveals why patients with rare leukemia develop resistance to tagraxofusp

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.

7 Jul 2026

Novel leukemia therapy successfully eradicates measurable residual disease

Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating with the antibody-drug conjugate (ADC) inotuzumab ozogamicin.

7 Jul 2026

Innovative polysaccharide hydrogels offer new hope for healing wounds

Announcing a new article publication in BIO Integration. Skin wound healing, especially in chronic non-healing conditions, such as diabetic foot ulcers and infected wounds, remains a formidable clinical challenge due to the complex pathophysiologic mechanisms and prolonged repair processes.

7 Jul 2026

New study identifies potential compound for pancreatic cancer treatment

Announcing a new article publication in BIO Integration. Fat mass and obesity-associated protein (FTO), an epitranscriptomic regulator, has been implicated in cancer progression and immune regulation but the therapeutic relevance in pancreatic cancer is unclear.

7 Jul 2026

Researchers identify brain circuits responsible for triggering OCD symptoms

Most of the time, the origin of obsessive-compulsive disorder (OCD) is unknown, but in some rare cases, it starts after a brain injury, such as a stroke or a tumor.

7 Jul 2026

New molecular mechanism identified in common inherited heart disease

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an international research team, has identified a new molecular mechanism involved in hypertrophic cardiomyopathy, the most common inherited cardiovascular disease.

7 Jul 2026

New artificial intelligence model reveals invisible multiple sclerosis lesions

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be impacted has been mostly invisible to clinicians.

7 Jul 2026

Adaptor proteins regulate macrophage behavior to control cancer growth

A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression."

7 Jul 2026

HonorHealth offers new drug that doubles pancreatic cancer survival

Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation to offer a new drug, Daraxonrasib, that based on early data nearly doubles the average survival time of patients with pancreatic cancer.

7 Jul 2026

New Mount Sinai center focuses on advancing personalized treatments for peanut allergy

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year, $7.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to establish a new Asthma and Allergic Diseases Cooperative Research Center focused on advancing personalized treatment strategies for peanut allergy.

7 Jul 2026

New drug candidate treats severe fatty liver disease by improving gut health

Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.

7 Jul 2026